Dietary modifications to reduce symptoms: Eat smaller, more frequent meals rather than three large meals, which can overwhelm delayed gastric emptying Choose bland, low-fat foods particularly during dose escalation periods Avoid trigger foods spicy, acidic, or heavily processed items that may exacerbate nausea Stay well hydrated sipping water throughout the day, especially if experiencing vomiting or diarrhoea Limit alcohol and caffeine both can irritate the gastric lining and worsen reflux Eat slowly and chew thoroughly supporting the digestive process Medication management considerations: Avoid NSAIDs when possible paracetamol is preferable for pain relief, as NSAIDs increase ulcer risk Review all medications with your pharmacist or GP to identify potential interactions Take Wegovy consistently same day each week, with or without food as preferred Consider timing of other medications while delayed gastric emptying generally has minimal effect on drug absorption, monitoring may be needed for medications with a narrow therapeutic index Lifestyle measures: Remain upright after eating for at least 30 minutes to reduce reflux Elevate the head of your bed if experiencing nocturnal reflux symptoms Manage stress which can exacerbate gastrointestinal symptoms Maintain physical activity as tolerated, supporting overall digestive function When symptoms persist despite these measures , discuss with your healthcare provider who may recommend: Domperidone has restricted use due to cardiac risks and should be avoided in certain conditions Proton pump inhibitors if significant reflux or dyspepsia develops, following NICE guidance (CG184) Dose adjustment temporarily reducing or maintaining current dose before further escalation Treatment interruption in cases of intolerable symptoms Regular communication with your healthcare team ensures optimal management of both weight loss goals and treatment tolerability, maximising the benefits of Wegovy whilst minimising adverse effects

Seniors can access brand-name Wegovy through NovoCare Pharmacy or participating retailers at these reduced cash prices
Clinical studies have demonstrated that Tirzepatide can lead to significant weight loss in adults with a high body mass index (BMI) when used as part of a comprehensive weight management plan
Your prescribing provider, surgeon, and anesthesiologist should communicate before your procedure
Retrieved March 29, 2016
Ambetter's coverage policy: Ozempic (semaglutide for diabetes): Covered with prior authorization for type 2 diabetes Wegovy (semaglutide for obesity): Not covered under any circumstance, even with prior authorization This creates a clinical and financial paradox